Shah Pratik has filed 20 insider transactions across 2 companies since February 2023.
Most recent transaction: a grant/award of 750000 shares of Design Therapeutics, Inc. ($DSGN) on January 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 2, 2026 | Design Therapeutics, Inc. | $DSGN | Shah Pratik | President, CEO and Chairperson | A | Stock option (right to buy) | 750000 | $0.00 | 750,000.0000 | 56,963,757 | 9999.99% | 1.32% |
| Dec. 9, 2025 | Design Therapeutics, Inc. | $DSGN | Shah Pratik | President, CEO and Chairperson | A | Stock option (right to buy) | 525000 | $0.00 | 525,000.0000 | 56,963,757 | 9999.99% | 0.92% |
| Dec. 9, 2025 | Design Therapeutics, Inc. | $DSGN | Shah Pratik | President, CEO and Chairperson | A | Stock option (right to buy) | 525000 | $0.00 | 525,000.0000 | 56,963,757 | 9999.99% | 0.92% |
| Nov. 12, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shah Pratik | Not found | G | Common Stock | 250000 | $0.00 | 4,574,554.0000 | 98,807,600 | 5.18% | 0.25% |
| Nov. 12, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shah Pratik | Not found | G | Common Stock | 100000 | $0.00 | 4,474,554.0000 | 98,807,600 | 2.19% | 0.10% |
| June 25, 2025 | ARS Pharmaceuticals, Inc. | $SPRY | Shah Pratik | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 102,390,828 | 9999.99% | 0.03% |
| Jan. 2, 2025 | Design Therapeutics, Inc. | $DSGN | Shah Pratik | President, CEO and Chairperson | A | Stock option (right to buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shah Pratik | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 95,215,322 | 9999.99% | 0.04% |
| June 13, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shah Pratik | Not found | G | Common Stock | 1132900 | $0.00 | 4,824,554.0000 | 95,215,322 | 19.02% | 1.19% |
| June 13, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shah Pratik | Not found | G | Common Stock | 200000 | $0.00 | 5,957,454.0000 | 95,215,322 | 3.25% | 0.21% |
| June 4, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shah Pratik | Not found | J | Common Stock | 2665800 | $0.00 | 7,490,404.0000 | 95,215,322 | 26.25% | 2.80% |
| June 7, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shah Pratik | Not found | G | Common Stock | 1332950 | $0.00 | 6,157,454.0000 | 95,215,322 | 17.80% | 1.40% |
| June 4, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shah Pratik | Not found | G | Common Stock | 1332900 | $0.00 | 7,490,404.0000 | 95,215,322 | 21.65% | 1.40% |
| June 4, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shah Pratik | Not found | J | Common Stock | 2665800 | $0.00 | 8,823,304.0000 | 95,215,322 | 23.20% | 2.80% |
| June 4, 2024 | ARS Pharmaceuticals, Inc. | $SPRY | Shah Pratik | Not found | G | Common Stock | 1332900 | $0.00 | 7,490,404.0000 | 95,215,322 | 15.11% | 1.40% |
| Sept. 1, 2023 | Design Therapeutics, Inc. | $DSGN | Shah Pratik | President, CEO and Chairperson | A | Stock Option (right to buy) | 525000 | $0.00 | 525,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 1, 2023 | Design Therapeutics, Inc. | $DSGN | Shah Pratik | President, CEO and Chairperson | A | Stock Option (right to buy) | 525000 | $0.00 | 525,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 1, 2023 | Design Therapeutics, Inc. | $DSGN | Shah Pratik | President, CEO and Chairperson | A | Stock Option (right to buy) | 1050000 | $0.00 | 1,050,000.0000 | 0 | 9999.99% | 0.00% |
| June 27, 2023 | ARS Pharmaceuticals, Inc. | $SPRY | Shah Pratik | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2023 | Design Therapeutics, Inc. | $DSGN | Shah Pratik | Executive Chairperson | A | Stock Option (right to buy) | 415000 | $0.00 | 415,000.0000 | 0 | 9999.99% | 0.00% |